Literature DB >> 22612046

The adult well male examination.

Joel J Heidelbaugh1, Michelle Tortorello.   

Abstract

The adult well male examination should incorporate evidence-based guidance toward the promotion of optimal health and well-being, including screening tests shown to improve health outcomes. Nearly one-third of men report not having a primary care physician. The medical history should include substance use; risk factors for sexually transmitted infections; diet and exercise habits; and symptoms of depression. Physical examination should include blood pressure and body mass index screening. Men with sustained blood pressures greater than 135/80 mm Hg should be screened for diabetes mellitus. Lipid screening is warranted in all men 35 years and older, and in men 20 to 34 years of age who have cardiovascular risk factors. Ultrasound screening for abdominal aortic aneurysm should occur between 65 and 75 years of age in men who have ever smoked. There is insufficient evidence to recommend screening men for osteoporosis or skin cancer. The U.S. Preventive Services Task Force has provisionally recommended against prostate-specific antigen-based screening for prostate cancer because the harms of testing and overtreatment outweigh potential benefits. Screening for colorectal cancer should begin at 50 years of age in men of average risk and continue until at least 75 years of age. Screening should be performed by high-sensitivity fecal occult blood testing every year, flexible sigmoidoscopy every five years combined with [corrected] fecal occult blood testing every three years. [corrected]. The U.S. Preventive Services Task Force recommends against screening for testicular cancer and chronic obstructive pulmonary disease. Immunizations should be recommended according to guidelines from the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention.

Entities:  

Mesh:

Year:  2012        PMID: 22612046

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  7 in total

Review 1.  Vitamin D and Gastrointestinal Cancers: A Narrative Review.

Authors:  Hemant Goyal; Abhilash Perisetti; M Rubayat Rahman; Avi Levin; Giuseppe Lippi
Journal:  Dig Dis Sci       Date:  2018-12-03       Impact factor: 3.199

2.  Physicians' Awareness and Utilization of Genetic Services in Texas.

Authors:  Callie Diamonstein; Blair Stevens; S Shahrukh Hashmi; Jerrie Refuerzo; Cathy Sullivan; Jennifer Hoskovec
Journal:  J Genet Couns       Date:  2017-12-26       Impact factor: 2.537

Review 3.  Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.

Authors:  Jayshree Mishra; Joseph Drummond; Sohel H Quazi; Satya Sridhar Karanki; J J Shaw; Ben Chen; Narendra Kumar
Journal:  Crit Rev Oncol Hematol       Date:  2012-10-23       Impact factor: 6.312

4.  Practice variations in voice treatment selection following vocal fold mucosal resection.

Authors:  Jaime E Moore; Paul J Rathouz; Jeffrey A Havlena; Qianqian Zhao; Seth H Dailey; Maureen A Smith; Caprice C Greenberg; Nathan V Welham
Journal:  Laryngoscope       Date:  2016-03-12       Impact factor: 3.325

5.  Recommendations for Treating Males: An Ethical Rationale for the Inclusion of Testicular Self-Examination (TSE) in a Standard of Care.

Authors:  Michael J Rovito; Janna Manjelievskaia; James E Leone; Michael Lutz; Chase T Cavayero; David Perlman
Journal:  Am J Mens Health       Date:  2015-12-03

Review 6.  Insight to drug delivery aspects for colorectal cancer.

Authors:  Arvind Gulbake; Aviral Jain; Ashish Jain; Ankit Jain; Sanjay K Jain
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

Review 7.  Vitamin D and gastrointestinal cancer.

Authors:  Ashish Mahendra; Basanta Kumar Choudhury; Tamanna Sharma; Neha Bansal; Richa Bansal; Shivangi Gupta
Journal:  J Lab Physicians       Date:  2018 Jan-Mar
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.